Cerebral perfusion and the risk of dementia: A population-based study

Circulation

Volumn 136, Issue 8, 2017, Pages 719-728

  Wolters, Frank J ^a,b   Zonneveld, Hazel I ^a   Hofman, Albert ^a,b   Van Der Lugt, Aad ^a   Koudstaal, Peter J ^a   Vernooij, Meike W ^a   Ikram, M Arfan ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alzheimer disease; Cerebral blood flow; Cerebral perfusion; Dementia; Epidemiology; Small vessel disease

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ALZHEIMER DISEASE; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CLINICAL ASSESSMENT; COGNITION; COGNITION ASSESSMENT; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY RISK; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENOTYPE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TWO-DIMENSIONAL IMAGING; WHITE MATTER; AGED; BRAIN CIRCULATION; DIAGNOSTIC IMAGING; HEALTH SURVEY; NETHERLANDS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CEREBROVASCULAR CIRCULATION; COHORT STUDIES; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NETHERLANDS; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RISK FACTORS; WHITE MATTER;

EID: 85021811277     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.027448     Document Type: Article

References (46)

1. Prince M, Comas-Herrera A, Knapp M, Guerchet M, Karagiannidou M; Alzheimer's Disease International. World Alzheimer Report 2016. September 2016. http://www.alz.co.uk/research/World Alzheimer Report2016.pdf. Accessed October 26, 2016.
2. Gardener H, Wright CB, Rundek T, Sacco RL. Brain health and shared risk factors for dementia and stroke. Nat Rev Neurol. 2015;11:651-657. doi: 10.1038/nrneurol.2015.195.
3. Qiu C, Fratiglioni L. A major role for cardiovascular burden in age-related cognitive decline. Nat Rev Cardiol. 2015;12:267-277. doi: 10.1038/nrcardio. 2014.223.
4. la Torre de JC. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J Alzheimers Dis. 2012;32:553-567.
5. Drachman DA. The amyloid hypothesis, time to move on: Amyloid is the downstream result, not cause, of Alzheimer's disease. Alzheimers Dement. 2014;10:372-380. doi: 10.1016/j.jalz.2013.11.003.
6. Binnewijzend MA, Kuijer JP, Benedictus MR, van der Flier WM, Wink AM, Wattjes MP, van Berckel BN, Scheltens P, Barkhof F. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology. 2013;267:221-230. doi: 10.1148/radiol.12120928.
7. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology. 2005;234:851-859. doi: 10.1148/radiol.2343040197.
8. van de Haar HJ, Jansen JFA, van Osch MJP, van Buchem MA, Muller M, Wong SM, Hofman PA, Burgmans S, Verhey FR, Backes WH. Neurovascular unit impairment in early Alzheimer's disease measured with magnetic resonance imaging. Neurobiol Aging. 2016;45:190-196.
9. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol. 2000;47:93-100.
10. Benedictus MR, Leeuwis AE, Binnewijzend MA, Kuijer JP, Scheltens P, Barkhof F, van der Flier WM, Prins ND. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease. Eur Radiol. 2017;27:1169-1175. doi: 10.1007/s00330-016-4450-z.
11. Mazza M, Marano G, Traversi G, Bria P, Mazza S. Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights. J Alzheimers Dis. 2011;23:375-389. doi: 10.3233/JAD-2010-090700.
12. Shi Y, Thrippleton MJ, Makin SD, Marshall I, Geerlings MI, de Craen AJ, van Buchem MA, Wardlaw JM. Cerebral blood flow in small vessel disease: a systematic review and meta-analysis. J Cereb Blood Flow Metab. 2016;36:1653-1667. doi: 10.1177/0271678X16662891.
13. Zonneveld HI, Loehrer EA, Hofman A, Niessen WJ, van der Lugt A, Krestin GP, Ikram MA, Vernooij MW. The bidirectional association between reduced cerebral blood flow and brain atrophy in the general population. J Cereb Blood Flow Metab. 2015;35:1882-1887. doi: 10.1038/jcbfm.2015.157.
14. Ruitenberg A, den Heijer T, Bakker SL, van Swieten JC, Koudstaal PJ, Hofman A, Breteler MM. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005;57:789-794. doi: 10.1002/ana.20493.
15. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2010;341:c3666.
16. Akoudad S, Wolters FJ, Viswanathan A, de Bruijn RF, van der Lugt A, Hofman A, Koudstaal PJ, Ikram MA, Vernooij MW. Association of cerebral microbleeds with cognitive decline and dementia. JAMA Neurol. 2016;73:934-943. doi: 10.1001/jamaneurol.2016.1017.
17. Yata K, Tomimoto H. Chronic cerebral hypoperfusion and dementia. Neurology and Clinical Neuroscience. 2014;2:129-134.
18. Wolters FJ, de Bruijn RF, Hofman A, Koudstaal PJ, Ikram MA; Heart Brain Connection Collaborative Research Group. Cerebral vasoreactivity, apolipoprotein E, and the risk of dementia: a population-based study. Arterioscler Thromb Vasc Biol. 2016;36:204-210. doi: 10.1161/ATVBAHA. 115.306768.
19. Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and dysfunction of the blood-brain barrier. Cell. 2015;163:1064-1078. doi: 10.1016/j. cell.2015.10.067.
20. Østergaard L, Engedal TS, Moreton F, Hansen MB, Wardlaw JM, Dalkara T, Markus HS, Muir KW. Cerebral small vessel disease: capillary pathways to stroke and cognitive decline. J Cereb Blood Flow Metab. 2016;36:302-325. doi: 10.1177/0271678X15606723.
21. Appelman AP, van der Graaf Y, Vincken KL, Mali WP, Geerlings MI. Combined effect of cerebral hypoperfusion and white matter lesions on executive functioning: the SMART-MR study. Dement Geriatr Cogn Disord. 2010;29:240-247. doi: 10.1159/000289813.
22. Hofman A, Brusselle GG, Darwish Murad S, van Duijn CM, Franco OH, Goedegebure A, Ikram MA, Klaver CC, Nijsten TE, Peeters RP, Stricker BH, Tiemeier HW, Uitterlinden AG, Vernooij MW. The Rotterdam Study: 2016 objectives and design update. Eur J Epidemiol. 2015;30:661-708. doi: 10.1007/s10654-015-0082-x.
23. Ikram MA, van der Lugt A, Niessen WJ, Koudstaal PJ, Krestin GP, Hofman A, Bos D, Vernooij MW. The Rotterdam Scan Study: design update 2016 and main findings. Eur J Epidemiol. 2015;30:1299-1315. doi: 10.1007/s10654-015-0105-7.
24. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Vrooman HA, Hofman A, Krestin GP, Breteler MM. Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam Scan Study. J Cereb Blood Flow Metab. 2008;28:412-419. doi: 10.1038/sj.jcbfm.9600526.
25. Spilt A, Box FM, van der Geest RJ, Reiber JH, Kunz P, Kamper AM, Blauw GJ, van Buchem MA. Reproducibility of total cerebral blood flow measurements using phase contrast magnetic resonance imaging. J Magn Reson Imaging. 2002;16:1-5. doi: 10.1002/jmri.10133.
26. Buijs PC, Krabbe-Hartkamp MJ, Bakker CJ, de Lange EE, Ramos LM, Breteler MM, Mali WP. Effect of age on cerebral blood flow: measurement with ungated two-dimensional phase-contrast MR angiography in 250 adults. Radiology. 1998;209:667-674. doi: 10.1148/radiology. 209.3.9844657.
27. Dolui S, Wang Z, Wang DJ, Mattay R, Finkel M, Elliott M, Desiderio L, Inglis B, Mueller B, Stafford RB, Launer LJ, Jacobs DR Jr, Bryan RN, Detre JA. Comparison of non-invasive MRI measurements of cerebral blood flow in a large multisite cohort. J Cereb Blood Flow Metab. 2016;36:1244-1256. doi: 10.1177/0271678X16646124.
28. Clark LR, Berman SE, Rivera-Rivera LA, Hoscheidt SM, Darst BF, Engelman CD, Rowley HA, Carlsson CM, Asthana S, Turski P, Wieben O, Johnson SC. Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease. Alzheimers Dement (Amst). 2017;7:48-55. doi: 10.1016/j.dadm.2017.01.002.
29. Vrooman HA, Cocosco CA, van der Lijn F, Stokking R, Ikram MA, Vernooij MW, Breteler MM, Niessen WJ. Multi-spectral brain tissue segmentation using automatically trained k-Nearest-Neighbor classification. Neuroimage. 2007;37:71-81. doi: 10.1016/j.neuroimage.2007.05.018.
30. Hoogendam YY, Hofman A, van der Geest JN, van der Lugt A, Ikram MA. Patterns of cognitive function in aging: the Rotterdam Study. Eur J Epidemiol. 2014;29:133-140. doi: 10.1007/s10654-014-9885-4.
31. de Bruijn RF, Bos MJ, Portegies ML, Hofman A, Franco OH, Koudstaal PJ, Ikram MA. The potential for prevention of dementia across two decades: the prospective, population-based Rotterdam Study. BMC Med. 2015;13:132. doi: 10.1186/s12916-015-0377-5.
32. Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364:656-665. doi: 10.1056/NEJMra0910283.
33. Block ML, Zecca L, Hong JS. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8:57-69. doi: 10.1038/nrn2038.
34. Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci. 2015;16:358-372. doi: 10.1038/nrn3880.
35. Barker R, Ashby EL, Wellington D, Barrow VM, Palmer JC, Kehoe PG, Esiri MM, Love S. Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. Brain. 2014;137(Pt 5):1524-1532. doi: 10.1093/brain/awu040.
36. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 2011;12:723-738. doi: 10.1038/nrn3114.
37. Wu Z, Guo H, Chow N, Sallstrom J, Bell RD, Deane R, Brooks AI, Kanagala S, Rubio A, Sagare A, Liu D, Li F, Armstrong D, Gasiewicz T, Zidovetzki R, Song X, Hofman F, Zlokovic BV. Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease. Nat Med. 2005;11:959-965. doi: 10.1038/nm1287.
38. Mattsson N, Tosun D, Insel PS, Simonson A, Jack CR Jr, Beckett LA, Donohue M, Jagust W, Schuff N, Weiner MW; Alzheimer's Disease Neuroimaging Initiative. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment. Brain. 2014;137(Pt 5):1550-1561. doi: 10.1093/brain/awu043.
39. Reitz C, Brickman AM, Brown TR, Manly J, De Carli C, Small SA, Mayeux R. Linking hippocampal structure and function to memory performance in an aging population. Arch Neurol. 2009;66:1385-1392. doi: 10.1001/archneurol.2009.214.
40. Gregg NM, Kim AE, Gurol ME, Lopez OL, Aizenstein HJ, Price JC, Mathis CA, James JA, Snitz BE, Cohen AD, Kamboh MI, Minhas D, Weissfeld LA, Tamburo EL, Klunk WE. Incidental cerebral microbleeds and cerebral blood flow in elderly individuals. JAMA Neurol. 2015;72:1021-1028. doi: 10.1001/jamaneurol.2015.1359.
41. Topakian R, Barrick TR, Howe FA, Markus HS. Blood-brain barrier permeability is increased in normal-appearing white matter in patients with lacunar stroke and leucoaraiosis. J Neurol Neurosurg Psychiatry. 2010;81:192-197. doi: 10.1136/jnnp.2009.172072.
42. Bakker SL, de Leeuw FE, de Groot JC, Hofman A, Koudstaal PJ, Breteler MM. Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly. Neurology. 1999;52:578-583.
43. Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, Frangione B, Blennow K, Ménard J, Zetterberg H, Wisniewski T, de Leon MJ. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11:457-470. doi: 10.1038/nrneurol.2015.119.
44. Arbel-Ornath M, Hudry E, Eikermann-Haerter K, Hou S, Gregory JL, Zhao L, Betensky RA, Frosch MP, Greenberg SM, Bacskai BJ. Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol. 2013;126:353-364. doi: 10.1007/s00401-013-1145-2.
45. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483-497. doi: 10.1016/S1474-4422(13)70060-7.
46. Østergaard L, Aamand R, Gutiérrez-Jiménez E, Ho YC, Blicher JU, Madsen SM, Nagenthiraja K, Dalby RB, Drasbek KR, Møller A, Brændgaard H, Mouridsen K, Jespersen SN, Jensen MS, West MJ. The capillary dysfunction hypothesis of Alzheimer's disease. Neurobiol Aging. 2013;34:1018-1031. doi: 10.1016/j.neurobiolaging.2012.09.011.